Juan Yang
PR China
Luzhou, Puerto Rico
Luzhou, Puerto Rico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Corrigendum to "A 68Ga-/177Lu-labeled theranostic pair targeting annexin A2 for precision management of breast cancer" [Bioorg. Chem. 166 (2025) 109149].
Journal: Bioorganic chemistry
Published: May 29, 2026
A 68Ga-/177Lu-labeled theranostic pair targeting annexin A2 for precision management of breast cancer.
Journal: Bioorganic chemistry
Published: September 01, 2025
Decoding resistome profiles and horizontal transfer of antibiotic resistance genes across the pork production chain under One Health sectors.
Journal: Food research international (Ottawa, Ont.)
Published: July 08, 2025
Label-free detection of single cell by ZnO/Graphene/AgNPs hybrid microcavity enhanced Raman scattering.
Journal: Frontiers in chemistry
Published: May 28, 2025
Tuning microstructure and surface chemistry of hard carbon for high-rate sodium-ion batteries.
Journal: Journal of colloid and interface science
Published: April 25, 2025
Bipyridine covalent organic framework aerogel for highly selective recovery of palladium in wastewater.
Journal: Chemical science
Published: December 23, 2024
Boosting oxygen reduction durability by embedding Co9S8 nanoparticles into Co single atoms anchored porous carbon frameworks.
Journal: Journal of colloid and interface science
Published: April 01, 2024
Rational Construction of a Triple-Phase Reaction Zone Using CuO-Based Heterostructure Nanoarrays for Enhanced Water Oxidation Reaction.
Journal: Inorganic chemistry
Published: December 02, 2023
Targeting estrogen mediated CYP4F2/CYP4F11-20-HETE metabolic disorder decelerates tumorigenesis in ER+ breast cancer.
Journal: Biochemistry and biophysics reports
Published: September 24, 2023
Upconversion nanoparticles@AgBiS2 core-shell nanoparticles with cancer-cell-specific cytotoxicity for combined photothermal and photodynamic therapy of cancers.
Journal: Bioactive materials
Published: December 13, 2021
MeCP2 drives hepatocellular carcinoma progression via enforcing HOXD3 promoter methylation and expression through the HB-EGF/EGFR pathway.
Journal: Molecular oncology
Published: January 25, 2021
Last Updated: 09/26/2026